Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004205744 | SCV003696941 | uncertain significance | not specified | 2022-09-28 | criteria provided, single submitter | clinical testing | The c.206C>T (p.S69L) alteration is located in exon 5 (coding exon 2) of the S100A13 gene. This alteration results from a C to T substitution at nucleotide position 206, causing the serine (S) at amino acid position 69 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |